文献速递消化道肿瘤与早癌消化内镜

结肠镜后结直肠癌的临床与分子特征

Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-03-29

在美国犹他州1995至2009年基于人群的横断面研究中,结肠镜后结直肠癌占全部结直肠癌的6%(159/2659),其中84例有组织标本并与84例结肠镜检出结直肠癌按年龄、性别和医院匹配。结肠镜后结直肠癌更多位于近端结肠(64% vs 44%,P=0.016)、多为早期(86% vs 69%,P=0.040),微卫星不稳定发生率为32% vs 13%(P=0.005);多变量logistic回归显示微卫星不稳定与结肠镜后结直肠癌相关(OR 4.20,95%CI 1.58-11.14),两组5年生存无差异。

要点

  • 结肠镜后结直肠癌占全部结直肠癌的6%(159/2659)。
  • 结肠镜后结直肠癌更多位于近端结肠(64% vs 44%)且多为早期(86% vs 69%)。
  • 微卫星不稳定与结肠镜后结直肠癌相关(OR 4.20,95%CI 1.58-11.14),两组5年生存无差异。

核心结论

  • 在犹他州基于人群的横断面研究中,结肠镜后结直肠癌更可能发生于近端结肠并表现为微卫星不稳定,结肠镜后结直肠癌与结肠镜检出结直肠癌似乎具有不同的肿瘤发生特征或过程。
  • 需要额外研究来确定结肠镜后癌症是否通过特定遗传途径发生。

研究设计与样本

  • 基于人群的横断面研究,纳入美国犹他州1995年至2009年 incident 结直肠癌病例。
  • 研究窗口内诊断结直肠癌2659例,其中6%(n=159)定义为结肠镜后结直肠癌;84例有组织可用,并与84例结肠镜检出结直肠癌按年龄、性别和医院匹配。
  • 结肠镜后结直肠癌定义为结肠镜检查后6至60个月内检测到的癌症,结肠镜检出结直肠癌定义为结肠镜检查后6个月内检测到的癌症。
  • 对存档标本检测微卫星不稳定、CpG岛甲基化以及KRAS和BRAF突变。

主要发现

  • 结肠镜后结直肠癌中近端结肠比例高于结肠镜检出结直肠癌(64% vs 44%;P=0.016)。
  • 结肠镜后结直肠癌中早期比例高于结肠镜检出结直肠癌(86% vs 69%;P=0.040)。
  • 结肠镜后结直肠癌中微卫星不稳定发生率为32%,结肠镜检出结直肠癌为13%(P=0.005)。
  • 其他分子特征在结肠镜后结直肠癌与结肠镜检出结直肠癌中比例相似。
  • 多变量logistic回归中,微卫星不稳定与结肠镜后结直肠癌相关(OR 4.20;95%CI 1.58-11.14)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要额外研究来确定结肠镜后癌症是否通过特定遗传途径发生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Post-colonoscopy colorectal cancers (PCCRCs) may arise from missed lesions or due to molecular features of tumors that allow them to grow rapidly. We aimed to compare clinical, pathology, and molecular features of PCCRCs (those detected within 6-60 months of colonoscopy) and detected CRCs (those detected within 6 months of a colonoscopy). METHODS: Within a population-based cross-sectional study of incident CRC cases in Utah (from 1995 through 2009), we identified PCCRCs (those cancers that developed within 5 years of a colonoscopy) and matched the patients by age, sex, and hospital site to patients with detected CRC. Archived specimens were retrieved and tested for microsatellite instability (MSI), CpG island methylation, and mutations in KRAS and BRAF. There were 2659 cases of CRC diagnosed within the study window; 6% of these (n = 159) were defined as PCCRCs; 84 of these cases had tissue available and were matched to 84 subjects with detected CRC. RESULTS: Higher proportions of PCCRCs than detected CRCs formed in the proximal colon (64% vs 44%; P = .016) and were of an early stage (86% vs 69%; P = .040). MSI was observed in 32% of PCCRCs compared with 13% of detected CRCs (P = .005). The other molecular features were found in similar proportions of PCCRCs and detected CRCs. In a multivariable logistic regression, MSI (odds ratio, 4.20; 95% CI, 1.58-11.14) was associated with PCCRC. There was no difference in 5-year survival between patients with PCCRCs vs detected CRCs. CONCLUSION: In this population-based cross-sectional study of incident CRC cases in Utah, we found PCCRCs to be more likely to arise in the proximal colon and demonstrate MSI, so PCCRCs and detected CRC appear to have different features or processes of tumorigenesis. Additional studies are needed to determine if post-colonoscopy cancers arise through a specific genetic pathway.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Samadder NJ, Neklason D, Snow A, et al. Clinical and Molecular Features of Post-Colonoscopy Colorectal Cancers. Clin Gastroenterol Hepatol. 2019. PMID: 30930275. doi:10.1016/j.cgh.2019.02.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。